FDA Drug recall D-179-2013
Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55…
- FDA Drug
- Class II
- terminated
- Published 2013-03-06
On 2013-03-06 the FDA classified a Class II recall of Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55… by Dr Reddy S Laboratories, citing chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-179-2013 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2012-08-01 |
| Published | 2013-03-06 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
Citalopram tablets USP, 20mg, 30-count bottle, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupalli, India 502 325, NDC 55111-343-30
Reason
Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.
Identifiers
| code_info | Lot #: C201922, Exp 1/14 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-179-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.